Ftse Mib
34.183,78
-0,33%
DAX
18.050,03
-0,45%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.551,54
-3,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Marinus Pharmaceuticals Inc (MRNS) Marinus Pharmaceuticals Inc (MRNS) Notizie

Marinus Pharmaceuticals Inc

MRNS
1,44
0,04 (2,86%)
Pre Mercato
Ultimo aggiornamento: 13:03:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/4/202413:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
05/4/202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27/3/202413:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
05/3/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
22/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20/2/202413:00BWMarinus Pharmaceuticals to Provide Business Update and..
16/2/202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
14/2/202422:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202418:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04/1/202413:04EDGAR2Form 8-K - Current report
04/1/202413:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
07/12/202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/11/202313:05EDGAR2Form 8-K - Current report
20/11/202322:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
14/11/202322:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
09/11/202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:11EDGAR2Form 8-K - Current report
07/11/202313:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/11/202313:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24/10/202313:01BWMarinus Pharmaceuticals to Provide Business Update and..
10/10/202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/10/202322:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/9/202313:05EDGAR2Form 8-K - Current report
21/9/202322:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19/9/202314:02EDGAR2Form 8-K - Current report
19/9/202314:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
12/9/202322:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
06/9/202322:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..
Apertura: Min: Max:
Chiusura: 1,40

La tua Cronologia

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network